NJIDEKA EMENYI: Open Payments
NPI 1912567504 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $194 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Indivior Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Corium, LLC | 1 | $29 |
| Alkermes, Inc. | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, Auvelity, SUBLOCADE, CAPLYTA, Azstarys, ARISTADA, Subvenite.
Industry payments across MD — which companies pay providers there.
